1. Clinical & Scientific Overview
Morphine Sulfate & Fentanyl (NDPS High-Alert Opioid Analgesics) (TIP-MED-000122, Reference Code [7.20]) is classified under
Pain, Inflammation, Rheumatology & Gout Medicines (Ch 07) as a Pure Mu-Opioid Receptor Agonists — Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT).
Within the Indian regulatory and compendial framework, it is governed under Schedule H1 / Schedule X & NDPS Act 1985 Psychotropic/Narcotic Prescription Drug (Strict Statutory Register).
Representative Indian Market Examples (Edition 2.7 Ch 07 [7.20], p. 88): Morphine: Morphitroy (Troikaa), Morcontin Continus (Modi Mundipharma), Vermor. Fentanyl: Durogesic Transdermal Patch (J&J), Fenstud, Trofentyl (IV) — Strengths & Dosage Forms: Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
3. Mechanism of Action & Pharmacodynamics
Pure Mu-Opioid Receptor Agonists — Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) acting on target receptor/enzyme pathways in Pain, Inflammation, Rheumatology & Gout Medicines (Ch 07): clinical efficacy is mediated via Pure Mu-Opioid Receptor Agonists — Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) for Moderate-to-severe cancer pain (WHO Step 3 Palliative Care Ladder), acute myocardial infarction / cardiogenic pulmonary oedema pain, severe postoperative/trauma pain (Fentanyl is preferred over Morphine in severe CKD Stage 4–5!).
4. Therapeutic Indications & Evidence-Supported Uses
- Moderate-to-severe cancer pain (WHO Step 3 Palliative Care Ladder), acute myocardial infarction / cardiogenic pulmonary oedema pain, severe postoperative/trauma pain (Fentanyl is preferred over Morphine in severe CKD Stage 4–5!)
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Morphine Oral (Opioid-Naive Cancer Pain): Start 5–10 mg IR PO q4h (plus 5 mg PRN breakthrough); once daily requirement is stable, convert to 12-hourly SR Morphine (half total 24h dose BD). Fentanyl Patch (ONLY in Opioid-Tolerant Patients taking >=60 mg/day oral Morphine equivalent!): Apply 1 patch to flat non-hairy upper torso/arm and replace every 72 hours
Administration & Meal Timing: Swallow Morphine SR/CR tablets whole; ALWAYS co-prescribe a stimulant + osmotic laxative (Bisacodyl/Senna + Lactulose/PEG) from Day 1 (tolerance NEVER develops to opioid constipation!) | Morphine IR: Every 4 hours around the clock. Morphine SR: Every 12 hours. Fentanyl Patch: Every 72 hours
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
7. Contraindications, Precautions & High-Risk Warnings
- NDPS ACT 1985 / ESSENTIAL NARCOTIC DRUGS (END) STATUTORY GOVERNANCE: Requires NDPS license/register, double-lock custody, and shift-to-shift balance! Contraindicated in respiratory depression, acute bronchial asthma, paralytic ileus, raised intracranial pressure/head injury. Fentanyl Patch is CONTRAINDICATED in opioid-naive patients or acute postoperative pain!
Key Clinical Precautions: Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
8. Adverse Effects Profile
- Constipation (near 100% without prophylactic laxatives!), nausea/vomiting (during first 5–7 days), drowsiness, miosis, pruritus, urinary retention
- Life-threatening respiratory depression (RR <8–10/min, pinpoint pupils, coma -> reverse STAT with Naloxone 0.04–0.4 mg IV titrated!), neuroexcitatory myoclonus/delirium in CKD (from M6G/M3G accumulation!), fatal Fentanyl overdose if patch is cut or exposed to heat/fever/hot-water bottle!
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Benzodiazepines, Zolpidem, Gabapentinoids, Alcohol, and Antihistamines cause synergistic fatal respiratory depression; CYP3A4 inhibitors (Clarithromycin, Itraconazole, Fluconazole, Diltiazem) markedly increase Fentanyl levels!
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: CRITICAL FENTANYL PATCH RULES: (1) Remove old patch before applying new patch every 72 hours; (2) NEVER cut a patch; (3) NEVER apply a heating pad/hot-water bottle over a patch or sit in hot water (heat increases Fentanyl absorption 3-fold and causes fatal overdose!); take your prescribed laxative daily with Morphine
- Meal & Clock Timing Instruction: Swallow Morphine SR/CR tablets whole; ALWAYS co-prescribe a stimulant + osmotic laxative (Bisacodyl/Senna + Lactulose/PEG) from Day 1 (tolerance NEVER develops to opioid constipation!) (Morphine IR: Every 4 hours around the clock. Morphine SR: Every 12 hours. Fentanyl Patch: Every 72 hours)
- Missed Dose Protocol: Take scheduled cancer-pain doses by the clock (do not wait for severe pain to return)
- Geriatric Dispensing Pearl: Start Morphine at 2.5–5 mg IR q4–6h in frail elderly; avoid Morphine if CrCl <30 mL/min
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 07 [7.20] (p. 88)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.